findmyKOL
Clinical trialNCT00272467CompletedPhase 4Interventional

Healing Effects of Rebamipide and Omeprazole in Helicobacter Pylori-positive Gastric Ulcer After Eradication Therapy

SponsorKorea Otsuka International Asia ArabEnrollment132Stomach Ulcer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China
  • Nanfang Hospital - Nanfang Medical Univ.

    Guangzhou, Guangdong, China

  • the 1st Affiliated Hospital - Zhongshan Univ.

    Guangzhou, Guangdong, China

  • Xijing Hospital - the 4th Military Medical Univ

    Xi’an, Shanxi, China

  • the 1st Affiliated Hospital - Medical School of Zhejiang Univ.

    Hangzhou, Zhejiang, China

  • Ren-Ji Hospital - Shanghai Second Medical Univ.

    Shanghai, China

South Korea
  • Korea University Ansan Hospital

    Ansan, South Korea

  • Severance Hospital, Seoul National University

    Seoul, South Korea

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jul 2005
Primary completion
30 Apr 2008
Completion
30 Apr 2008
Last update posted
29 Apr 2015
Registered enrollment
132
Registry id
NCT00272467

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.